We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Roche and Exiqon Agree on Joint Marketing Approach for their RT PCR Assay  Systems
News

Roche and Exiqon Agree on Joint Marketing Approach for their RT PCR Assay Systems

Roche and Exiqon Agree on Joint Marketing Approach for their RT PCR Assay  Systems
News

Roche and Exiqon Agree on Joint Marketing Approach for their RT PCR Assay Systems

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Roche and Exiqon Agree on Joint Marketing Approach for their RT PCR Assay Systems"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

As indicated by respective links on their websites, each system will complement the cooperator ´s product portfolio.  A bundle of measures like webinars and seminars and linked internet appearances are planned to promote the joint offer. Financial terms of the agreement were not disclosed.
 
Roche Applied Science´s RealTime ready assays offer maximized testing efficiency.  Targets of choice are selectable out of gene lists of functionally related gene families or biological pathways. They can be ordered as single assays or configured as custom panel on a LightCycler® 480 Multiwell Plate. The function tested qPCR assays based on the proven Universal ProbeLibrary technology enable for optimum results, with detailed bioinformatics background information and novel error-detection features. The RealTime ready assays allow for discovery of the functionality of targets in complex biological pathways, to research their influence on processes leading to diseases or disorders.

Exiqon's miRCURY LNA™ Universal RT microRNA PCR system offers a combination of performance and ease-of-use on the microRNA real-time PCR market. The use of LNA™-enhanced PCR primers secures exceptional sensitivity and specificity enabling accurate quantification of very low amounts of microRNA obtained from difficult samples such as FFPE, serum/plasma and laser capture microscopy. The product line which includes reagents for the LightCycler® 480 System consists of microRNA Ready-to-Use PCR panels for expression profiling of human and rodent microRNAs, individual microRNA assays, reference genes and reagent kits.

Advertisement